All Stories

  1. Increased platelet reactivity in Klinefelter men: something new to consider
  2. Maternal hypothyroidism and subsequent neuropsychological outcome of the progeny: a family portrait
  3. Testicular parenchymal abnormalities in Klinefelter syndrome: a question of cancer? Examination of 40 consecutive patients
  4. Long-term outcomes of laparoscopic adrenalectomy for Cushing disease
  5. Impact of prophylactic central compartment neck dissection on locoregional recurrence of differentiated thyroid cancer in clinically node-negative patients: A retrospective study of a large clinical series
  6. Current concepts of pheochromocytoma
  7. The role of surgery in the current management of differentiated thyroid cancer
  8. The Role of Survivin in Thyroid Tumors: Differences of Expression in Well-Differentiated, Non–Well-Differentiated, and Anaplastic Thyroid Cancers
  9. Prognostic implications of node metastatic features in OSCC: a retrospective study on 121 neck dissections
  10. Cardiovascular abnormalities in Klinefelter Syndrome
  11. High circulating levels of CCL2 in patients with Klinefelter's syndrome
  12. Laparoscopic adrenalectomy, a safe procedure for pheochromocytoma. A retrospective review of clinical series
  13. Total thyroidectomy, without prophylactic central lymph node dissection, in the treatment of differentiated thyroid cancer. Clinical retrospective study on 221 cases
  14. Predictive value of nodal metastases on local recurrence in the management of differentiated thyroid cancer. Retrospective clinical study
  15. Multifocal thoracic chordoma mimicking a paraganglioma
  16. Laparoscopic adrenal surgery: ten-year experience in a single institution
  17. Lessons to be learned from the clinical management of a MEN 2A patient bearing a novel 634/640/700 mutation of theRETproto-oncogene
  18. A Unique Patient Presenting With Concomitant Klinefelter Syndrome, Alport Syndrome, and Craniopharyngioma
  19. Epigenetic fingerprint in endometrial carcinogenesis: The hypothesis of a uterine field cancerization
  20. Upregulation of Endocrine Gland-Derived Vascular Endothelial Growth Factor in Papillary Thyroid Cancers Displaying Infiltrative Patterns, Lymph Node Metastases, and BRAF Mutation
  21. CDKN1B V109G polymorphism a new prognostic factor in sporadic medullary thyroid carcinoma
  22. Expression of RIZ1 protein (Retinoblastoma-interacting zinc-finger protein 1) in prostate cancer epithelial cells changes with cancer grade progression and is modulated in vitro by DHT and E2
  23. Effect of long-term cabergoline therapy on the immunological pattern and pituitary function of patients with idiopathic hyperprolactinaemia positive for antipituitary antibodies
  24. Survivin gene-expression and splicing isoforms in oral squamous cell carcinoma
  25. Effects of somatostatin analogue SOM230 on cell proliferation, apoptosis and catecholamines levels in cultured pheochromocytoma cells
  26. Antipituitary Antibodies against Gonadotropin-Secreting Cells in Adult Male Patients with Apparently Idiopathic Hypogonadotropic Hypogonadism
  27. The Endocrine-Gland-Derived Vascular Endothelial Growth Factor (EG-VEGF)/Prokineticin 1 and 2 and Receptor Expression in Human Prostate: Up-Regulation of EG-VEGF/Prokineticin 1 with Malignancy
  28. Natural and Synthetic Retinoids in Prostate Cancer
  29. Characterization of antipituitary antibodies targeting pituitary hormone-secreting cells in idiopathic growth hormone deficiency and autoimmune endocrine diseases
  30. Differential effects of all-trans-retinoic acid (RA) on Erk1/2 phosphorylation and cAMP accumulation in normal and malignant human prostate epithelial cells: Erk1/2 inhibition restores RA-induced decrease of cell growth in malignant prostate cells
  31. Fenofibrate increases the expression of high mobility group AT-hook 2 (HMGA2) gene and induces adipocyte differentiation of orbital fibroblasts from Graves' ophthalmopathy
  32. Verapamil inhibits interleukin-6 and vascular endothelial growth factor production in primary cultures of keloid fibroblasts
  33. All-trans retinoic acid- and N-(4-hydroxyphenil)-retinamide-induced growth arrest and apoptosis in orbital fibroblasts in Graves’ disease
  34. Loss of oestrogen receptor beta, high PCNA and p53 expression and aneuploidy as markers of worse prognosis in ovarian granulosa cell tumours
  35. Somatostatin Receptor Genes Are Expressed in Lymphocytes from Retroorbital Tissues in Graves’ Disease
  36. EPN: A NOVEL EPITHELIAL CELL LINE DERIVED FROM HUMAN PROSTATE TISSUE
  37. Estrogen receptor β expression in human prostate tissue
  38. Loss of Estrogen Receptor   Expression in Malignant Human Prostate Cells in Primary Cultures and in Prostate Cancer Tissues
  39. ANTISPERM ANTIBODIES IN CRYPTORCHIDISM BEFORE AND AFTER SURGERY
  40. Endocrine Secretions under Abnormal Light-Dark Cycles and in the Blind
  41. Retinoic acid receptors alpha, beta and gamma, and cellular retinol binding protein-I expression in breast fibrocystic disease and cancer
  42. Different Expression Patterns of Somatostatin Receptor Subtypes in Cultured Epithelial Cells from Human Normal Prostate and Prostate Cancer
  43. Abnormal level of retinoic acid in prostate cancer tissues
  44. Late Gonadal Function and Autoimmunization in Familial Testicular Torsion